Biogen (BIIB) Return on Assets [ROA] (2009 - 2026)
Biogen's Return on Assets [ROA] was 1.08% in Q3 2026, down 4.51 percentage points from 5.59% a year earlier and down 1.63 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Biogen came in at 4.50%, down 1.45 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -11.16 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 5.95% in FY2024 (+1.43 pp), 4.52% in FY2023 (-7.71 pp), 12.23% in FY2022 (+5.11 pp) and 7.12% in FY2021 (-8.54 pp).
- The Q3 2026 figure marks the lowest quarterly Return on Assets [ROA] in data going back to Q3 2009.
- Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of -0.74 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2023 (a gain of 6.25 percentage points); the worst was Q4 2021 (a drop of 9.14 percentage points).
- Per Business Quant data, BIIB's Return on Assets [ROA] in the three quarters before Q3 2026 was 2.71% (Q2 2026), 4.66% (Q1 2026) and 4.41% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 2.00% |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 1.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.08% |
| Jun 30, 2026 | 2.71% |
| Mar 31, 2026 | 4.66% |
| Dec 31, 2025 | 4.41% |
| Sep 30, 2025 | 5.59% |
| Jun 30, 2025 | 5.43% |
| Mar 31, 2025 | 5.28% |
| Dec 31, 2024 | 5.79% |
| Sep 30, 2024 | 5.86% |
| Jun 30, 2024 | 4.34% |
| Mar 31, 2024 | 4.37% |
| Dec 31, 2023 | 4.22% |
| Sep 30, 2023 | 5.48% |
| Jun 30, 2023 | 10.71% |
| Mar 31, 2023 | 12.74% |
| Dec 31, 2022 | 11.99% |
| Sep 30, 2022 | 9.58% |
| Jun 30, 2022 | 6.47% |
| Mar 31, 2022 | 6.49% |
| Dec 31, 2021 | 7.25% |
API Access
Biogen Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();